Sign in

CIK 0001420720 · Non-accelerated filer<br>Smaller reporting company

iBio, Inc.

Sign in to watch
Ticker
IBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
operating
EIN
262797813
Phone
302 355-0650
Business address
600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
Former names
iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
  1. 8-K Event Results of operations · Shareholder vote results
  2. SC 13G Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 8-K Event Regulation FD disclosure
  7. ARS Other Annual Report to Security Holders
  8. DEF 14A Proxy Proxy Statement
  9. 10-K/A Report 10-K/A
  10. 10-K Report Annual Report
  11. 8-K Event Results of operations
  12. 3 Insider Initial Statement of Ownership
  13. EFFECT Other Notice of Effectiveness
  14. 424B5 Offering Prospectus
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. 8-K Event Executive or director change
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. S-3/A Offering Registration Statement
  19. UPLOAD Other SEC-generated Letter
  20. 8-K Event Executive or director change · Code of ethics change

Page 9 of 46 · 911 filings